.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Predict branded drug patent expiration

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
UBS
Fish and Richardson
Moodys
Farmers Insurance
Cerilliant
Cantor Fitzgerald
Covington
Merck
US Army

Generated: June 29, 2017

DrugPatentWatch Database Preview

PREMARIN Drug Profile

« Back to Dashboard

What is the patent landscape for Premarin, and when can generic versions of Premarin launch?

Premarin is a drug marketed by Wyeth Pharms Inc and is included in three NDAs.

The generic ingredient in PREMARIN is estrogens, conjugated. There are three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the estrogens, conjugated profile page.

Summary for Tradename: PREMARIN

Patents:0
Applicants:1
NDAs:3
Suppliers / Packagers: see list8
Bulk Api Vendors: see list25
Clinical Trials: see list45
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PREMARIN at DailyMed

Pharmacology for Tradename: PREMARIN

Ingredient-typeEstrogens, Conjugated (USP)
Drug ClassEstrogen
Mechanism of ActionEstrogen Receptor Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
INJECTABLE;INJECTION010402-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
TABLET;ORAL004782-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
TABLET;ORAL004782-006Jul 16, 2003RXYesNo► Subscribe► Subscribe
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
TABLET;ORAL004782-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
CREAM;TOPICAL, VAGINAL020216-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PREMARIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
TABLET;ORAL004782-004Approved Prior to Jan 1, 19825,210,081► Subscribe
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
TABLET;ORAL004782-001Approved Prior to Jan 1, 19825,210,081► Subscribe
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
INJECTABLE;INJECTION010402-001Approved Prior to Jan 1, 19825,210,081► Subscribe
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
TABLET;ORAL004782-003Approved Prior to Jan 1, 19825,210,081► Subscribe
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
TABLET;ORAL004782-002Approved Prior to Jan 1, 19825,210,081► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Dow
Argus Health
Chinese Patent Office
Cipla
Fish and Richardson
QuintilesIMS
Deloitte
Accenture
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot